APA (7th ed.) Citation

HG, J., ZK, Z., LM, T., YL, C., MQ, C., GB, G., . . . L, T. (2026). Oridonin exerts dual therapeutic effects in MASLD mice by integrating lipid homeostasis and drug bioactivation via the LXRα-CES1/CES2 pathway. Acta pharmacologica Sinica, 47(6), 1617. https://doi.org/10.1038/s41401-025-01737-x

Chicago Style (17th ed.) Citation

HG, Jiang, Zhan ZK, Tian LM, Chen YL, Cai MQ, Ge GB, Chen X, Wei CL, and Tang L. "Oridonin Exerts Dual Therapeutic Effects in MASLD Mice by Integrating Lipid Homeostasis and Drug Bioactivation via the LXRα-CES1/CES2 Pathway." Acta Pharmacologica Sinica 47, no. 6 (2026): 1617. https://doi.org/10.1038/s41401-025-01737-x.

MLA (9th ed.) Citation

HG, Jiang, et al. "Oridonin Exerts Dual Therapeutic Effects in MASLD Mice by Integrating Lipid Homeostasis and Drug Bioactivation via the LXRα-CES1/CES2 Pathway." Acta Pharmacologica Sinica, vol. 47, no. 6, 2026, p. 1617, https://doi.org/10.1038/s41401-025-01737-x.